Kinnevik Results Presentation Deck

WE CONTINUED TO EXECUTE ON OUR 2023 PRIORITIES IN Q2, ACCRETING OWNERSHIP IN SPRING HEALTH AND TRAVELPERK Spring Health Note: TravelPerk babylon CHARM Key Events of The Quarter Q2 2023 NAV of SEK 54.0bn or 192 per share, down 3% in Q2 2023 and 12% over the last twelve months. Unlisted investments up SEK 2.5bn in the quarter through SEK 2.1bn in net investments and a minor write-up of underlying valuations Continuing our accretion of ownership in Spring Health through a USD 100m purchase of existing shares, making the company our largest aggregate investment since we began our transformation to growth in 2018 Invested USD 19m in TravelPerk. Since our first investment in the travel management platform in 2018, we have quadrupled our invested capital and the company has grown revenues by >30x Babylon Health announced it has agreed to be taken private through a transaction supported by the company's main creditor. Electing not to participate in the transaction, we have written off our investment in full Added Charm Industrial, a San Francisco-based carbon dioxide removal company, to our portfolio through a USD 10m investment Net Asset Value adjusted for Other Net Assets / Liabilities We exceeded our portfolio climate target both year-over-year and on an average annual basis in 2022, which we disclosed in our Climate Progress Report released in June Net Asset Value • Public, Private, Net Cash/ (Debt), SEKbn 61.1 13.6 19.0 29.3 Q2 2022 55.5 Investments 3.1 10.5. 15.8 29.9 Q1 2023 Investment Activity H1 2023, SEKbn Divestments (1.0) 54.0 8.8 13.7 32.5 Q2 2023 Net Investments 2.1 KINNEVIK

View entire presentation